Bacterial manipulation of innate immunity to promote infection

Nature Reviews Microbiology

Volumn 8, Issue 2, 2010, Pages 117-128

  Diacovich, Lautaro ^a   Gorvel, Jean Pierre ^a,b  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b Foundation FINOVI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; BACTERIAL ANTIGEN;

APOPTOSIS; AUTOPHAGY; BACTERIAL INFECTION; BACTERIAL REPRODUCTION; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL INVASION; CELL MEMBRANE TRANSPORT; CYTOKINE PRODUCTION; ENDOCYTOSIS; EXOCYTOSIS; FRANCISELLA TULARENSIS; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; INTERNALIZATION; INTRACELLULAR BACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; RESPIRATORY BURST; REVIEW; SALMONELLA TYPHIMURIUM; SHIGELLA; YERSINIA; ACTIVE IMMUNIZATION; ANIMAL; BACTERIUM; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; VIRULENCE;

BACTERIA (MICROORGANISMS); MAMMALIA;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIA; BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, INNATE; VIRULENCE;

EID: 75749096311     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2295     Document Type: Review

References (150)

1. Alexopoulou, L. & Kontoyiannis, D. Contribution of microbial-associated molecules in innate mucosal responses. Cell. Mol. Life Sci. 62, 1349-1358 (2005).
2. Hibino, T. et al. The immune gene repertoire encoded in the purple sea urchin genome. Dev. Biol. 300, 349-365 (2006).
3. Akashi-Takamura, S. & Miyake, K. TLR accessory molecules. Curr. Opin. Immunol. 20, 420-425 (2008).
4. Kumar, Y. & Valdivia, R. H. Leading a sheltered life: intracellular pathogens and maintenance of vacuolar compartments. Cell Host Microbe 5, 593-601 (2009).
5. Neyrolles, O. et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One 1, e43 (2006).
6. Tailleux, L., Maeda, N., Nigou, J., Gicquel, B. & Neyrolles, O. How is the phagocyte lectin keyboard played? Master class lesson by Mycobacterium tuberculosis. Trends Microbiol. 11, 259-263 (2003).
7. Yadav, M. & Schorey, J. S. The β-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108, 3168-3175 (2006).
8. Korbel, D. S., Schneider, B. E. & Schaible, U. E. Innate immunity in tuberculosis: myths and truth. Microbes Infect. 10, 995-1004 (2008).
9. Flannagan, R. S., Cosio, G. & Grinstein, S. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nature Rev. Microbiol. 7, 355-366 (2009).
10. Cooper, A. M. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27, 393-422 (2009).
11. Bonazzi, M., Lecuit, M. & Cossart, P. Listeria monocytogenes internalin and E-cadherin: from structure to pathogenesis. Cell. Microbiol. 11, 693-702 (2009).
12. Dehio, C. Bartonella interactions with endothelial cells and erythrocytes. Trends Microbiol. 9, 279-285 (2001).
13. Kubori, T. et al. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280, 602-605 (1998).
14. Unsworth, K. E., Way, M., McNiven, M., Machesky, L. & Holden, D. W. Analysis of the mechanisms of Salmonella-induced actin assembly during invasion of host cells and intracellular replication. Cell. Microbiol. 6, 1041-1055 (2004).
15. Patel, J. C. & Galan, J. E. Manipulation of the host actin cytoskeleton by Salmonella-all in the name of entry. Curr. Opin. Microbiol. 8, 10-15 (2005).
16. Patel, J. C., Rossanese, O. W. & Galan, J. E. The functional interface between Salmonella and its host cell: opportunities for therapeutic intervention. Trends Pharmacol. Sci. 26, 564-570 (2005).
17. Patel, J. C. & Galan, J. E. Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J. Cell Biol. 175, 453-463 (2006).
18. Kaniga, K., Uralil, J., Bliska, J. B. & Galan, J. E. A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol. Microbiol. 21, 633-641 (1996).
19. Li, G. & Zhang, X. C. GTP hydrolysis mechanism of Ras-like GTPases. J. Mol. Biol. 340, 921-932 (2004).
20. Fu, Y. & Galan, J. E. A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature 401, 293-297 (1999).
21. Murli, S., Watson, R. O. & Galan, J. E. Role of tyrosine kinases and the tyrosine phosphatase SptP in the interaction of Salmonella with host cells. Cell. Microbiol. 3, 795-810 (2001).
22. Haraga, A. & Miller, S. I. A Salmonella enterica serovar typhimurium translocated leucine-rich repeat effector protein inhibits NF-κ B-dependent gene expression. Infect. Immun. 71, 4052-4058 (2003).
23. Collier-Hyams, L. S. et al. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-κ B pathway. J. Immunol. 169, 2846-2850 (2002).
24. Nhieu, G. T. & Sansonetti, P. J. Mechanism of Shigella entry into epithelial cells. Curr. Opin. Microbiol. 2, 51-55 (1999).
25. Lafont, F., Tran Van Nhieu, G., Hanada, K., Sansonetti, P. & van der Goot, F. G. Initial steps of Shigella infection depend on the cholesterol/ sphingolipid raft-mediated CD44-IpaB interaction. EMBO J. 21, 4449-4457 (2002).
26. 2 into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21, 5069-5078 (2002).
27. Salcedo, S. P. et al. Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog. 4, e21 (2008).
28. Newman, R. M., Salunkhe, P., Godzik, A. & Reed, J. C. Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect. Immun. 74, 594-601 (2006).
29. Cirl, C. et al. Subversion of Toll-like receptor signalling by a unique family of bacterial Toll/ interleukin-1 receptor domain-containing proteins. Nature Med. 14, 399-406 (2008).
30. Radhakrishnan, G. K., Yu, Q., Harms, J. S. & Splitter, G. A. Brucella TIR domain-containing protein mimics properties of the toll-like receptor adaptor protein TIRAP. J. Biol. Chem. 284, 9892-9898 (2009).
31. Lapaque, N., Moriyon, I., Moreno, E. & Gorvel, J. P. Brucella lipopolysaccharide acts as a virulence factor. Curr. Opin. Microbiol. 8, 60-66 (2005).
32. Fugier, E., Pappas, G. & Gorvel, J. P. Virulence factors in brucellosis: implications for aetiopathogenesis and treatment. Expert Rev. Mol. Med. 9, 1-10 (2007).
33. Ganguly, N. et al. Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-κB transactivation by downregulation of reactive oxidative species (ROS) production. Immunol. Cell Biol. 86, 98-106 (2008).
34. Ganguly, N. et al. Mycobacterium tuberculosis 6-kDa early secreted antigenic target (ESAT-6) protein downregulates lipopolysaccharide induced c-myc expression by modulating the extracellular signal regulated kinases 1/2. BMC Immunol. 8, 24 (2007).
35. High, N., Mounier, J., Prevost, M. C. & Sansonetti, P. J. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 11, 1991-1999 (1992).
36. Pizarro-Cerda, J. & Cossart, P. Subversion of cellular functions by Listeria monocytogenes. J. Pathol. 208, 215-223 (2006).
37. Corr, S. C. & O'Neill, L. A. Listeria monocytogenes infection in the face of innate immunity. Cell. Microbiol. 11, 703-709 (2009).
38. Goldberg, M. B. Actin-based motility of intracellular microbial pathogens. Microbiol. Mol. Biol. Rev. 65, 595-626 (2001).
39. Perrin, A. J., Jiang, X., Birmingham, C. L., So, N. S. & Brumell, J. H. Recognition of bacteria in the cytosol of mammalian cells by the ubiquitin system. Curr. Biol. 14, 806-811 (2004).
40. de Chastellier, C., Forquet, F., Gordon, A. & Thilo, L. Mycobacterium requires an all-around closely apposing phagosome membrane to maintain the maturation block and this apposition is re-established when it rescues itself from phagolysosomes. Cell. Microbiol.1 1, 1190-1207 (2009).
41. Fratti, R. A., Backer, J. M., Gruenberg, J., Corvera, S. & Deretic, V. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J. Cell Biol. 154, 631-644 (2001).
42. Philips, J. A. Mycobacterial manipulation of vacuolar sorting. Cell. Microbiol. 10, 2408-2415 (2008).
43. Vergne, I. et al. Mechanism of phagolysosome biogenesis block by viable Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 102, 4033-4038 (2005).
44. Shabaana, A. K. et al. Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling. Cell. Mol. Life Sci. 62, 179-187 (2005).
45. Welin, A. et al. Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect. Immun. 76, 2882-2887 (2008).
46. Robinson, N. et al. Mycobacterial phenolic glycolipid inhibits phagosome maturation and subverts the pro-inflammatory cytokine response. Traffic 9, 1936-1947 (2008).
47. Axelrod, S. et al. Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide. Cell. Microbiol. 10, 1530-1545 (2008).
48. Vergne, I., Chua, J. & Deretic, V. Mycobacterium tuberculosis phagosome maturation arrest: selective targeting of PI3P-dependent membrane trafficking. Traffic 4, 600-606 (2003).
49. Meresse, S., Steele-Mortimer, O., Finlay, B. B. & Gorvel, J. P. The rab7 GTPase controls the maturation of Salmonella typhimurium-containing vacuoles in HeLa cells. EMBO J. 18, 4394-4403 (1999).
50. Knodler, L. A. & Steele-Mortimer, O. Taking possession: biogenesis of the Salmonella-containing vacuole. Traffic 4, 587-599 (2003).
51. Galan, J. E. Interaction of Salmonella with host cells through the centisome 63 type III secretion system. Curr. Opin. Microbiol. 2, 46-50 (1999).
52. Mukherjee, K., Parashuraman, S., Raje, M. & Mukhopadhyay, A. SopE acts as an Rab5-specific nucleotide exchange factor and recruits non-prenylated Rab5 on Salmonella-containing phagosomes to promote fusion with early endosomes. J. Biol. Chem. 276, 23607-23615 (2001).
53. Cirillo, D. M., Valdivia, R. H., Monack, D. M. & Falkow, S. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 30, 175-188 (1998).
54. Hensel, M. et al. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 30, 163-174 (1998).
55. Uchiya, K. et al. A Salmonella virulence protein that inhibits cellular trafficking. EMBO J. 18, 3924-3933 (1999).
56. Lee, A. H., Zareei, M. P. & Daefler, S. Identification of a NIPSNAP homologue as host cell target for Salmonella virulence protein SpiC. Cell. Microbiol. 4, 739-750 (2002).
57. Garcia-del Portillo, F., Zwick, M. B., Leung, K. Y. & Finlay, B. B. Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells. Proc. Natl Acad. Sci. USA 90, 10544-10548 (1993).
58. Brumell, J. H., Goosney, D. L. & Finlay, B. B. SifA, a type III secreted effector of Salmonella typhimurium, directs Salmonella-induced filament (Sif) formation along microtubules. Traffic 3, 407-415 (2002).
59. Stein, M. A., Leung, K. Y., Zwick, M., Garcia-del Portillo, F. & Finlay, B. B. Identification of a Salmonella virulence gene required for formation of filamentous structures containing lysosomal membrane glycoproteins within epithelial cells. Mol. Microbiol. 20, 151-164 (1996).
60. Beuzon, C. R. et al. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. EMBO J. 19, 3235-3249 (2000).
61. Brumell, J. H., Tang, P., Mills, S. D. & Finlay, B. B. Characterization of Salmonella-induced filaments (Sifs) reveals a delayed interaction between Salmonella-containing vacuoles and late endocytic compartments. Traffic 2, 643-653 (2001).
62. Salcedo, S. P., Noursadeghi, M., Cohen, J. & Holden, D. W. Intracellular replication of Salmonella typhimurium strains in specific subsets of splenic macrophages in vivo. Cell. Microbiol. 3, 587-597 (2001).
63. Arellano-Reynoso, B. et al. Cyclic β-1, 2-glucan is a Brucella virulence factor required for intracellular survival. Nature Immunol. 6, 618-625 (2005).
64. Fugier, E. et al. The glyceraldehyde-3-phosphate dehydrogenase and the small GTPase Rab 2 are crucial for Brucella replication. PLoS Pathog. 5, e1000487 (2009).
65. Roy, C. R., Salcedo, S. P. & Gorvel, J. P. Pathogen-endoplasmic- reticulum interactions: in through the out door. Nature Rev. Immunol. 6, 136-147 (2006).
66. Ninio, S. & Roy, C. R. Effector proteins translocated by Legionella pneumophila: strength in numbers. Trends Microbiol. 15, 372-380 (2007).
67. Wyrick, P. B. Intracellular survival by Chlamydia. Cell. Microbiol. 2, 275-282 (2000).
68. Heuer, D. et al. Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature 457, 731-735 (2009).
69. Radtke, A. L. & O'Riordan, M. X. Intracellular innate resistance to bacterial pathogens. Cell. Microbiol. 8, 1720-1729 (2006).
70. Nauseef, W. M. Assembly of the phagocyte NADPH oxidase. Histochem. Cell. Biol. 122, 277-291 (2004).
71. MacMicking, J., Xie, Q. W. & Nathan, C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15, 323-350 (1997).
72. Bogdan, C. Nitric oxide and the immune response. Nature Immunol. 2, 907-916 (2001).
73. Lowenstein, C. J. & Padalko, E. iNOS (NOS2) at a glance. J. Cell Sci. 11 7, 2865-2867 (2004).
74. Chakravortty, D. & Hensel, M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect. 5, 621-627 (2003).
75. Fang, F. C. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nature Rev. Microbiol. 2, 820-832 (2004).
76. De Groote, M. A. et al. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl Acad. Sci. USA 94, 13997-14001 (1997).
77. Farrant, J. L. et al. Bacterial copper-and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis. Mol. Microbiol. 25, 785-796 (1997).
78. Fang, F. C. et al. Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases. Proc. Natl Acad. Sci. USA 96, 7502-7507 (1999).
79. Linehan, S. A. & Holden, D. W. The interplay between Salmonella typhimurium and its macrophage host-what can it teach us about innate immunity? Immunol. Lett. 85, 183-192 (2003).
80. Lundberg, B. E., Wolf, R. E. Jr, Dinauer, M. C., Xu, Y. & Fang, F. C. Glucose 6-phosphate dehydrogenase is required for Salmonella typhimurium virulence and resistance to reactive oxygen and nitrogen intermediates. Infect. Immun. 67, 436-438 (1999).
81. van der Straaten, T. et al. Novel Salmonella enterica serovar Typhimurium protein that is indispensable for virulence and intracellular replication. Infect. Immun. 69, 7413-7418 (2001).
82. -/-) mice. Infect. Immun. 70, 2614-2621 (2002).
83. Bryk, R., Griffin, P. & Nathan, C. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407, 211-215 (2000).
84. Chen, L., Xie, Q. W. & Nathan, C. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol. Cell 1, 795-805 (1998).
85. Husain, M. et al. Nitric oxide evokes an adaptive response to oxidative stress by arresting respiration. J. Biol. Chem. 283, 7682-7689 (2008).
86. Jaeger, T. et al. Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis. Arch. Biochem. Biophys. 423, 182-191 (2004).
87. Jaeger, T. Peroxiredoxin systems in mycobacteria. Subcell. Biochem. 44, 207-217 (2007).
88. Sherman, D. R. et al. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272, 1641-1643 (1996).
89. Fischer, K. et al. Mycobacterial lysocardiolipin is exported from phagosomes upon cleavage of cardiolipin by a macrophage-derived lysosomal phospholipase A2. J. Immunol. 167, 2187-2192 (2001).
90. Bang, I. S. et al. Maintenance of nitric oxide and redox homeostasis by the Salmonella flavohemoglobin hmp. J. Biol. Chem. 281, 28039-28047 (2006).
91. Darwin, K. H. & Nathan, C. F. Role for nucleotide excision repair in virulence of Mycobacterium tuberculosis. Infect. Immun. 73, 4581-4587 (2005).
92. Cowley, S. C., Myltseva, S. V. & Nano, F. E. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol. Microbiol. 20, 867-874 (1996).
93. Eriksson, S. et al. Salmonella typhimurium mutants that downregulate phagocyte nitric oxide production. Cell. Microbiol. 2, 239-250 (2000).
94. Vazquez-Torres, A. et al. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287, 1655-1658 (2000).
95. Shiloh, M. U. et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10, 29-38 (1999).
96. Gallois, A., Klein, J. R., Allen, L. A., Jones, B. D. & Nauseef, W. M. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 166, 5741-5748 (2001).
97. Vazquez-Torres, A., Fantuzzi, G., Edwards, C. K. 3rd, Dinarello, C. A. & Fang, F. C. Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumour necrosis factor p55 receptor-deficient macrophages. Proc. Natl Acad. Sci. USA 98, 2561-2565 (2001).
98. Cherayil, B. J., McCormick, B. A. & Bosley, J. Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2. Infect. Immun. 68, 5567-5574 (2000).
99. Bjur, E., Eriksson-Ygberg, S. & Rhen, M. The O-antigen affects replication of Salmonella enterica serovar Typhimurium in murine macrophage-like J774-A.1 cells through modulation of host cell nitric oxide production. Microbes Infect. 8, 1826-1838 (2006).
100. Chakravortty, D., Hansen-Wester, I. & Hensel, M. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195, 1155-1166 (2002).
101. Miller, B. H. et al. Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection. Infect. Immun. 72, 2872-2878 (2004).
102. Davis, A. S. et al. Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. PLoS Pathog. 3, e186 (2007).
103. Forbes, J. R. & Gros, P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102, 1884-1892 (2003).
104. Chlosta, S. et al. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 74, 3065-3067 (2006).
105. De Voss, J. J. et al. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc. Natl Acad. Sci. USA 97, 1252-1257 (2000).
106. Parent, M. A. et al. Brucella abortus siderophore 2, 3-dihydroxybenzoic acid (DHBA) facilitates intracellular survival of the bacteria. Microb. Pathog. 32, 239-248 (2002).
107. Fischbach, M. A., Lin, H., Liu, D. R. & Walsh, C. T. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nature Chem. Biol. 2, 132-138 (2006).
108. Chatterjee, S. S. et al. Intracellular gene expression profile of Listeria monocytogenes. Infect. Immun. 74, 1323-1338 (2006).
109. Jansen, A. & Yu, J. Differential gene expression of pathogens inside infected hosts. Curr. Opin. Microbiol. 9, 138-142 (2006).
110. Levine, B. & Deretic, V. Unveiling the roles of autophagy in innate and adaptive immunity. Nature Rev. Immunol. 7, 767-777 (2007).
111. Schmid, D. & Munz, C. Innate and adaptive immunity through autophagy. Immunity 27, 11-21 (2007).
112. Orvedahl, A. & Levine, B. Eating the enemy within: autophagy in infectious diseases. Cell Death Differ. 16, 57-69 (2009).
113. Dorn, B. R., Dunn, W. A. Jr & Progulske-Fox, A. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect. Immun. 69, 5698-5708 (2001).
114. Gutierrez, M. G. et al. Autophagy induction favours the generation and maturation of the Coxiella-replicative vacuoles. Cell. Microbiol. 7, 981-993 (2005).
115. Birmingham, C. L. et al. Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles. Nature 451, 350-354 (2008).
116. Swanson, M. S. & Molofsky, A. B. Autophagy and inflammatory cell death, partners of innate immunity. Autophagy 1, 174-176 (2005).
117. Suzuki, T. et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 3, e111 (2007).
118. Schroeder, G. N. & Hilbi, H. Cholesterol is required to trigger caspase-1 activation and macrophage apoptosis after phagosomal escape of Shigella. Cell. Microbiol. 9, 265-278 (2007).
119. Suzuki, T. & Nunez, G. A role for Nod-like receptors in autophagy induced by Shigella infection. Autophagy 4, 73-75 (2008).
120. Ogawa, M. et al. Escape of intracellular Shigella from autophagy. Science 307, 727-731 (2005).
121. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
122. Meylan, E., Tschopp, J. & Karin, M. Intracellular pattern recognition receptors in the host response. Nature 442, 39-44 (2006).
123. Ting, J. P. et al. The NLR gene family: a standard nomenclature. Immunity 28, 285-287 (2008).
124. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426 (2002).
125. Kanneganti, T. D., Lamkanfi, M. & Nunez, G. Intracellular NOD-like receptors in host defense and disease. Immunity 27, 549-559 (2007).
126. Mariathasan, S. & Monack, D. M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nature Rev. Immunol. 7, 31-40 (2007).
127. Martinon, F. & Tschopp, J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14, 10-22 (2007).
128. Fernandes-Alnemri, T. et al. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14, 1590-1604 (2007).
129. Yu, H. B. & Finlay, B. B. The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 4, 198-208 (2008).
130. Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 11 7, 561-574 (2004).
131. Keller, M., Ruegg, A., Werner, S. & Beer, H. D. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132, 818-831 (2008).
132. Shao, W., Yeretssian, G., Doiron, K., Hussain, S. N. & Saleh, M. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282, 36321-36329 (2007).
133. Kanneganti, T. D. et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233-236 (2006).
134. Mariathasan, S. et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232 (2006).
135. Faustin, B. et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25, 713-724 (2007).
136. Martinon, F., Agostini, L., Meylan, E. & Tschopp, J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14, 1929-1934 (2004).
137. Pan, Q. et al. MDP-induced interleukin-1β processing requires Nod2 and CIAS1/NALP3. J. Leukoc. Biol. 82, 177-183 (2007).
138. Hsu, L. C. et al. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1 (3 secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl Acad. Sci. USA 105, 7803-7808 (2008).
139. Franchi, L. et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1(3 in salmonella-infected macrophages. Nature Immunol. 7, 576-582 (2006).
140. Miao, E. A. et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1(3 via Ipaf. Nature Immunol. 7, 569-575 (2006).
141. Kanneganti, T. D. et al. Critical role for Cryopyrin/ Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281, 36560-36568 (2006).
142. Kanneganti, T. D. et al. Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signalling. Immunity 26, 433-443 (2007).
143. Piccini, A. et al. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1 (3 and IL-18 secretion in an autocrine way. Proc. Natl Acad. Sci. USA 105, 8067-8072 (2008).
144. Weiss, D. S. et al. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl Acad. Sci. USA 104, 6037-6042 (2007).
145. Master, S. S. et al. Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe 3, 224-232 (2008).
146. Ruckdeschel, K. et al. Yersinia enterocolitica impairs activation of transcription factor NF-KB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumour necrosis factor a production. J. Exp. Med. 187, 1069-1079 (1998).
147. Schesser, K. et al. The yopJ locus is required for Yersinia-mediated inhibition of NF-KB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol. Microbiol. 28, 1067-1079 (1998).
148. Schotte, P. et al. Targeting Rac1 by the Yersinia effector protein YopE inhibits caspase-1-mediated maturation and release of interleukin-1 (3. J. Biol. Chem. 279, 25134-25142 (2004).
149. Dukuzumuremyi, J. M. et al. The Yersinia protein kinase A is a host factor inducible RhoA/Rac-binding virulence factor. J. Biol. Chem. 275, 35281-35290 (2000).
150. Bergsbaken, T. & Cookson, B. T. Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 3, e161 (2007).